1. Home
  2. BCE vs TEVA Comparison

BCE vs TEVA Comparison

Compare BCE & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BCE Inc.

BCE

BCE Inc.

HOLD

Current Price

$23.56

Market Cap

21.5B

Sector

N/A

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$28.38

Market Cap

30.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCE
TEVA
Founded
1880
1901
Country
Canada
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.5B
30.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BCE
TEVA
Price
$23.56
$28.38
Analyst Decision
Hold
Strong Buy
Analyst Count
3
8
Target Price
$29.50
$27.00
AVG Volume (30 Days)
2.9M
11.4M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
5.36%
N/A
EPS Growth
7324.86
N/A
EPS
4.80
0.62
Revenue
$17,579,277,614.00
$16,776,000,000.00
Revenue This Year
$1.89
$4.74
Revenue Next Year
$3.03
$0.48
P/E Ratio
$4.95
$46.12
Revenue Growth
0.11
0.02
52 Week Low
$20.28
$12.47
52 Week High
$27.28
$28.68

Technical Indicators

Market Signals
Indicator
BCE
TEVA
Relative Strength Index (RSI) 56.45 80.93
Support Level $23.10 $24.01
Resistance Level $23.77 $26.96
Average True Range (ATR) 0.39 0.68
MACD 0.07 0.19
Stochastic Oscillator 86.45 94.65

Price Performance

Historical Comparison
BCE
TEVA

About BCE BCE Inc.

BCE provides wireless, broadband, television, and landline phone services in Canada. It is one of the Big Three national wireless carriers, with over 10 million customers constituting about 30% of the market. It is also the incumbent local exchange carrier—the legacy telephone provider—throughout much of the eastern half of Canada, including in the most populous Canadian provinces: Ontario and Quebec. BCE has a media segment that holds television, radio, and digital media assets. BCE licenses the Canadian rights to HBO Max and Starz.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: